Pathogenic mutations in exon 22 of BRCA1 and exon 27 of BRCA2 disrupt DNA repair mechanisms, leading to genomic instability and increased risk of cancer and progression [3,4,22]. This evidence concerns the gene BRCA2 and cancer.